文献速递心外重症与机械循环支持

HeartMate II 左心室辅助装置肋下更换的远期结局:一则警示

Late outcomes of subcostal exchange of the HeartMate II left ventricular assist device: a word of caution.
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

单中心回顾性总结2004年3月至2017年7月41例(占568例植入者的7.2%)经肋下切口行HeartMate II更换者的早期与远期结局;共48次更换,无院内死亡,30天生存率100%、1年94.6%,但1年免于左心室辅助装置相关感染为79.3%、免于装置血栓与卒中均为74.4%。

要点

  • 肋下更换无院内死亡,30天生存率100%,1年生存率94.6%。
  • 更换后10例(25%)发生左心室辅助装置相关感染,1年免于感染79.3%。
  • 13例(32%)因泵血栓需第2次更换,1年免于装置血栓与卒中均为74.4%。

核心结论

  • 肋下泵更换可安全施行,但感染与复发性血栓风险较高,必须对远期并发症进行仔细随访。

研究设计与样本

  • 单中心研究,2004年3月至2017年7月本院568例HeartMate II植入者中41例(7.2%)经肋下切口行装置更换,总结早期与远期结局。

主要发现

  • 41例患者共行48次肋下泵更换,全部手术成功且无院内死亡。
  • 更换指征为装置血栓31例(76%)、驱动线感染2例(5%)、驱动线损伤8例(19%)。
  • Kaplan-Meier曲线示肋下更换后30天与1年生存率分别为100%与94.6%。
  • 10例(25%)更换后发生左心室辅助装置相关感染,包括7例泵袋感染与3例驱动线感染,1年免于该感染为79.3%。
  • 13例(32%)因泵血栓致装置故障需第2次更换,7例复发血栓,3例(7%)发生卒中,1年免于装置血栓与免于卒中事件均为74.4%。

临床怎么用

  • 作者认为肋下泵更换可安全施行,但感染与复发性血栓风险较高,必须对远期并发症进行仔细随访。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Previous studies have shown the usefulness of the subcostal exchange of the HeartMate II left ventricular assist device for device malfunction. However, long-term data are still limited. METHODS: Between March 2004 and July 2017, 41 of 568 (7.2%) patients who had received a HeartMate II implant at our institution had a device exchange via a subcostal incision. We summarized early and late outcomes. RESULTS: Forty-one patients had a total of 48 subcostal pump exchanges. Indications for device exchange included device thrombosis (n = 31, 76%), driveline infection (n = 2, 5%) and driveline injury (n = 8, 19%). All of the procedures were successful, and there were no in-hospital deaths. A Kaplan-Meier survival curve showed 30-day and 1-year survival rates after subcostal exchange of 100% and 94.6%, respectively. However, 10 (25%) patients had left ventricular assist device-related infections following subcostal exchange that included 7 pump pocket infections and 3 driveline infections. Freedom from left ventricular assist device-related infection at 1 year after subcostal exchange was 79.3%. Thirteen (32%) patients had device malfunction due to pump thrombosis that required a 2nd device exchange. Seven patients had recurrent thrombosis. Three (7%) patients had a stroke. Freedom from device thrombosis and from a stroke event at 1 year was 74.4%. CONCLUSIONS: Subcostal pump exchange can be safely performed. However, there is a substantial risk of infection and recurrent thrombosis. Careful follow-up for late complications is mandatory.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Yu SN, Takayama H, Han J, et al. Late outcomes of subcostal exchange of the HeartMate II left ventricular assist device: a word of caution. Eur J Cardiothorac Surg. 2018. PMID: 29648627. doi:10.1093/ejcts/ezy159

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。